3 Patents 40,700,000 Potentially Impacted
* Alzamend Neuro is working on two patented therapeutics licensed from the University of South Florida. Ault Life Sciences is a shareholder in Alzamend Neuro who directly owns licences to the drugs and patents.”
* * CONTACT US
TOGETHER WE CAN ACHIEVE MORE
* * 3 Patents * Alzamend Neuro is working on two patented therapeutics licensed from the University of South Florida. Ault Life Sciences is a shareholder in Alzamend Neuro who directly owns licences to the drugs and patents.”
40,700,000 Potentially Impacted
LEADING ALZHEIMER'S RESEARCHER TALKS ABOUT LITHIUM ALTERNATIVE
AULT LIFE SCIENCES WORKING WITH UNIVERSITIES
Ault Life Sciences invests in disruptive technologies and processes in the biotechnology and health care sectors. Although our structure may be corporate, our approach with our stakeholders is one of partnership. Our proactive value-added investment approach combined with our team’s diligence and expertise has us strategically positioned for explosive growth in the near future.
Disciplined focus on neuro-degenerative diseases and the biotechnology sector where Ault Life Sciences expertise can drive exponential growth.
In my 30 years on Wall Street, I have come to understand the risks and rewards associated with investing in innovative life science companies. Having benefited from numerous successful transactions in this sector, I have now created a new venture, Ault Life Sciences. This was done to both support a promising new company (Alzamend Neuro) in advancing two treatments for Alzheimer’s disease and to uncover additional promising companies and technologies with a focus on treating neuro-degenerative diseases. Our leadership team and network of scientific experts are in position as we look to capture the tremendous upside potential of the life sciences sector.